Earnings Ahead

CBAY - CymaBay Therapeutics Inc.

7.8 -0.26 -3.23

CymaBay Therapeutics Inc.

CymaBay Therapeutics Inc.

About

Profile


Headquarters

Newark, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CBAY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02
  • CymaBay Therapeutics Q3 2022 Earnings Preview
  • CymaBay Therapeutics GAAP EPS of -$0.31 misses by $0.01
  • CymaBay Therapeutics Q2 2022 Earnings Preview
  • GH, FUV and CBAY among after hour movers.
  • CymaBay Therapeutics stock gains after CEO buys shares worth $100K
  • CymaBay announces result from two-year study of primary biliary cholangitis therapy
  • CymaBay price target lowered at H.C. Wainwright on enrollment delay for key study
  • CymaBay Therapeutics GAAP EPS of -$0.32 misses by $0.01
  • CymaBay Therapeutics Q1 2022 Earnings Preview
  • CymaBay announces result from Phase 2 trial of primary biliary cholangitis therapy
  • CymaBay Therapeutics GAAP EPS of -$0.34 misses by $0.11
  • CymaBay Therapeutics Q4 2021 Earnings Preview
  • CymaBay on the rise after insider purchase of chief medical officer
  • CymaBay Therapeutics prices ~$75M offering
  • CymaBay Therapeutics announces public offering of common stock and warrants
  • CymaBay Therapeutics shares long-term bio marker data for liver disease therapy
  • CymaBay Therapeutics EPS misses by $0.08
  • CymaBay Therapeutics Q3 2021 Earnings Preview
  • CymaBay Therapeutics EPS misses by $0.07
PEERS
XLV
Date Price Open High Low Vol ER
Mar 23 3.240 3.360
3.400
3.230
303.88K
Mar 22 3.390 3.210
3.405
3.170
464.99K
Mar 21 3.210 3.180
3.310
3.179
467.94K
Mar 18 3.150 3.180
3.540
3.110
2.33M
Mar 17 3.180 3.040
3.200
3.035
563.29K
 
Mar 16 3.050 3.050
3.110
2.935
524.29K
Mar 15 2.970 3.000
3.040
2.910
320.61K
Mar 14 2.970 3.230
3.230
2.940
427.46K
Mar 11 3.210 3.340
3.390
3.210
238.49K
Mar 10 3.330 3.350
3.410
3.285
276.44K
Mar 9 3.400 3.210
3.410
3.200
338.28K
Mar 8 3.180 3.150
3.250
3.090
205.97K
Mar 7 3.150 3.140
3.245
3.075
338.63K
Mar 4 3.130 3.130
3.229
3.105
232.48K
Mar 3 3.160 3.280
3.310
3.100
223.73K
Mar 2 3.250 3.290
3.290
3.195
206.63K
Mar 1 3.270 3.170
3.300
3.170
235.67K
Feb 28 3.180 3.190
3.270
3.160
333.15K
Feb 25 3.230 3.240
3.255
3.140
261.44K
Feb 24 3.220 3.070
3.260
3.010
442.41K